Julius Emons
ORCID: 0000-0002-2520-4443
· 5 papers in corpus
other
2026
BACKGROUND: Treatment with NovaSure® endometrial ablation is approved for patients with heavy menstrual bleeding (HMB) without evidence of malignant or premalignant lesions. This analysis addresses the rare but clinically relevant situation…
observational
2026
OBJECTIVE: Evaluation of retrospective outcomes of NovaSure treatment in patients with abnormal uterine bleeding, including safety and cost-effectiveness, and risk factors related to therapeutic outcomes. Subgroup analysis was conducted for…
other
2026
Background: Minimally invasive interventional radiology (IR) offers effective, uterus-preserving treatments for several gynecologic and obstetric conditions such as uterine fibroids, adenomyosis and postpartum hemorrhage. Despite their effi…
observational
2026
BACKGROUND: For the first time, an S3 guideline on complementary medicine in oncology was published in 2021, 2024 in May version 2.0 was published. The broad spectrum of complementary and integrative medicine was presented at the highest le…
case-report
2024
Ureterocele as differential diagnosis of hydrosalpinx-an interesting case from the clinical practice
Hydrosalpinx is a common condition in women of reproductive age that correlates with infertility. A ureterocele is a dilatation of the terminal ureter within the bladder and/or urethra that occurs seldomly in adults, but can sonographically…